The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
Open accessAbstract
Currently, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly known as 2019-nCoV, the causative pathogen of Coronavirus Disease 2019 (COVID-19)) has rapidly spread across China and around the world, causing an outbreak of acute infectious pneumonia. No specific anti-virus drugs or vaccines are available for the treatment of this sudden and lethal disease. The supportive care and non-specific treatment to ameliorate the symptoms of the patient are the only options currently. At the top of these conventional therapies, greater than 85% of SARS-CoV-2 infected patients in China are receiving Traditional Chinese Medicine (TCM) treatment. In this article, relevant published literatures are thoroughly reviewed and current applications of TCM in the treatment of COVID-19 patients are analyzed. Due to the homology in epidemiology, genomics, and pathogenesis of the SARS-CoV-2 and SARS-CoV, and the widely use of TCM in the treatment of SARS-CoV, the clinical evidence showing the beneficial effect of TCM in the treatment of patients with SARS coronaviral infections are discussed. Current experiment studies that provide an insight into the mechanism underlying the therapeutic effect of TCM, and those studies identified novel naturally occurring compounds with anti-coronaviral activity are also introduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,361
Self-citationF. T. Z. H. O. W. U. N. C. M. A. R. T., Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,254
Self-citationXu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,205
Self-citationClinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,008
Xie, X., Zhong, Z., Zhao, W., Zheng, C., Wang, F., & Liu, J. (2020) · Radiology · doi:10.1148/radiol.2020200343 · Cited by 1,960
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571
Return of the Coronavirus: 2019-nCoV
Gralinski, L. E., & Menachery, V. D. (2020) · Viruses · doi:10.3390/v12020135 · Cited by 1,348
Potential interventions for novel coronavirus in China: A systematic review
Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,348
The Severe Acute Respiratory Syndrome
Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,346
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13615-x · Cited by 1,158
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Lu, H. (2020) · BioScience Trends · doi:10.5582/bst.2020.01020 · Cited by 1,133
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Arabi, Y. M., Mandourah, Y., Al-Hameed, F., Sindi, A. A., Almekhlafi, G. A., Hussein, M. A., Jose, J., Pinto, R., Al-Omari, A., Kharaba, A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1172oc · Cited by 1,122
Fugh-Berman, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06457-0 · Cited by 1,099
(2006) · Pharmacodynamic Basis of Herbal Medicine, Second Edition · doi:10.1201/9781420006452.ch4 · Cited by 905
Inhibition of SARS-CoV 3CL protease by flavonoids
Jo, S., Kim, S., Shin, D. H., & Kim, M.-S. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1690480 · Cited by 685
Luo, H., Tang, Q.-L., Shang, Y.-X., Liang, S.-B., Yang, M., Robinson, N., & Liu, J.-P. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-020-3192-6 · Cited by 613
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
LI, S., CHEN, C., ZHANG, H., GUO, H., WANG, H., WANG, L., ZHANG, X., HUA, S., YU, J., & XIAO, P. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.02.007 · Cited by 602
New insights into the antiviral effects of chloroquine
Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Lin, C.-W., Tsai, F.-J., Tsai, C.-H., Lai, C.-C., Wan, L., Ho, T.-Y., Hsieh, C.-C., & Chao, P.-D. L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.07.002 · Cited by 545
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T., Fan, K. W., Cheng, V. C. C., Tsui, W. H. W., Hung, I. F. N., & Lee, T. S. W. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.003 · Cited by 534
Small molecules targeting severe acute respiratory syndrome human coronavirus
Wu, C.-Y., Jan, J.-T., Ma, S.-H., Kuo, C.-J., Juan, H.-F., Cheng, Y.-S. E., Hsu, H.-H., Huang, H.-C., Wu, D., Brik, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403596101 · Cited by 521
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
HO, T., WU, S., CHEN, J., LI, C., & HSIANG, C. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2006.04.014 · Cited by 516
Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11334-11339.2004 · Cited by 485
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445
Yu, M.-S., Lee, J., Lee, J. M., Kim, Y., Chin, Y.-W., Jee, J.-G., Keum, Y.-S., & Jeong, Y.-J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.081 · Cited by 422
Ng, A. W. T., Poon, S. L., Huang, M. N., Lim, J. Q., Boot, A., Yu, W., Suzuki, Y., Thangaraju, S., Ng, C. C. Y., Tan, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan6446 · Cited by 381
He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 366
Yan, Y., Zou, Z., Sun, Y., Li, X., Xu, K.-F., Wei, Y., Jin, N., & Jiang, C. (2013) · Cell Research · doi:10.1038/cr.2012.165 · Cited by 353
Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
Nguyen, T. T. H., Woo, H.-J., Kang, H.-K., Nguyen, V. D., Kim, Y.-M., Kim, D.-W., Ahn, S.-A., Xia, Y., & Kim, D. (2012) · Biotechnology Letters · doi:10.1007/s10529-011-0845-8 · Cited by 347
The Novel Coronavirus: A Bird's Eye View
Habibzadeh, P., & Stoneman, E. K. (2020) · The International Journal of Occupational and Environmental Medicine · doi:10.15171/ijoem.2020.1921 · Cited by 307
Hyperimmune IV Immunoglobulin Treatment
Hung, I. F. N., To, K. K. W., Lee, C.-K., Lee, K.-L., Yan, W.-W., Chan, K., Chan, W.-M., Ngai, C.-W., Law, K.-I., Chow, F.-L., et al. (2013) · Chest · doi:10.1378/chest.12-2907 · Cited by 286
Corticosteroids as adjunctive therapy in the treatment of influenza
Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J., & Lim, W. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010406.pub2 · Cited by 264
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, E., Titecat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 248
Ding, Y., Zeng, L., Li, R., Chen, Q., Zhou, B., Chen, Q., Cheng, P. L., Yutao, W., Zheng, J., Yang, Z., et al. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1585-7 · Cited by 243
Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors
Jo, S., Kim, H., Kim, S., Shin, D. H., & Kim, M. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13604 · Cited by 242
Kaempferol Derivatives as Antiviral Drugs against the 3a Channel Protein of Coronavirus
Schwarz, S., Sauter, D., Wang, K., Zhang, R., Sun, B., Karioti, A., Bilia, A., Efferth, T., & Schwarz, W. (2014) · Planta Medica · doi:10.1055/s-0033-1360277 · Cited by 231
Chen, X., Yang, L., Zhang, N., Turpin, J. A., Buckheit, R. W., Osterling, C., Oppenheim, J. J., & Howard, O. M. Z. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2810-2816.2003 · Cited by 225
Self-citationTraditional Chinese herbal medicine as a source of molecules with antiviral activity
Li, T., & Peng, T. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2012.10.006 · Cited by 223
New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections
De Clercq, E. (2019) · Chemistry – An Asian Journal · doi:10.1002/asia.201900841 · Cited by 216
Corticosteroids as adjunctive therapy in the treatment of influenza
Lansbury, L., Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J., & Lim, W. S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010406.pub3 · Cited by 193
Emodin inhibits current through SARS-associated coronavirus 3a protein
Schwarz, S., Wang, K., Yu, W., Sun, B., & Schwarz, W. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.02.008 · Cited by 189
Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication
Chen, C.-J., Michaelis, M., Hsu, H.-K., Tsai, C.-C., Yang, K. D., Wu, Y.-C., Cinatl, J., & Doerr, H. W. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.07.048 · Cited by 165
Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)
Liu, X., Zhang, M., He, L., & Li, Y. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004882.pub3 · Cited by 149
Self-citationBurki, T. K. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30056-4 · Cited by 149
Nucleosides for the treatment of respiratory RNA virus infections
Jordan, P. C., Stevens, S., & Deval, J. (2018) · Antiviral chemistry & chemotherapy · doi:10.1177/2040206618764483 · Cited by 145
Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS
Chen, Z., & Nakamura, T. (2004) · Phytotherapy Research · doi:10.1002/ptr.1485 · Cited by 124
Chinese Herbal Medicine for Severe Acute Respiratory Syndrome: A Systematic Review and Meta-Analysis
Liu, J., Manheimer, E. W., Shi, Y. P., & Gluud, C. N. (2004) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2004.10.1041 · Cited by 120
Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.
Chen, X., Beutler, J. A., McCloud, T. G., Loehfelm, A., Yang, L., Dong, H., Chertov, O., Salcedo, R., Oppenheim, J. J., & Howard, O. M. Z. (2003) · PubMed · Cited by 99
Self-citationPoon, P. M. K., Wong, C. K., Fung, K., Fong, C., Wong, E. L., Lau, J. T. F., Leung, P. C. K., Tsui, S. K., Wan, D. C., Waye, M. M. Y., et al. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x0600359x · Cited by 92
Lau, J. T. F., Leung, P., Wong, E. L., Fong, C., Cheng, K.-F., Zhang, S. C., Lam, C. W. K., Wong, V. C. W., Choy, K. M., & Ko, W. M. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.49 · Cited by 85
Effect of integrated traditional Chinese and Western medicine on SARS: A review of clinical evidence
Zhang, M., Liu, X.-M., & He, L. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i23.3500 · Cited by 85
Inhibitory activities of baicalin against renin and angiotensin-converting enzyme
Deng, Y., Aluko, R. E., Jin, Q., Zhang, Y., & Yuan, L. (2011) · Pharmaceutical Biology · doi:10.3109/13880209.2011.608076 · Cited by 82
Using Herbal Medicine as a Means of Prevention Experience During the SARS Crisis
Lau, T. F., Leung, P. C. K., Wong, E. L., Fong, C., Cheng, K.-F., Zhang, S., Lam, C. W. K., WONG, V. C. W., Choy, K. M., & Ko, W. M. (2005) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x05002965 · Cited by 79
Lin, H.-X., Feng, Y., Wong, G., Wang, L., Li, B., Zhao, X., Li, Y., Smaill, F., & Zhang, C. (2008) · Journal of General Virology · doi:10.1099/vir.0.83331-0 · Cited by 78
Self-citationChen, X., Murakami, T., Oppenheim, J. J., & Howard, O. M. Z. (2005) · Blood · doi:10.1182/blood-2005-03-0854 · Cited by 77
Self-citationWang, W., Ma, X., Han, J., Zhou, M., Ren, H., Pan, Q., Zheng, C., & Zheng, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146197 · Cited by 75
Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean
Takahashi, S., Yoshiya, T., Yoshizawa‐Kumagaye, K., & Sugiyama, T. (2015) · Biomedical Research · doi:10.2220/biomedres.36.219 · Cited by 62
Chen, X., Yang, D., Shen, W., Dong, H., Wang, J. M., Oppenheim, J. J., & Howard, O. M. Z. (2000) · Inflammation Research · doi:10.1007/s000110050656 · Cited by 60
Self-citationChen, X., Oppenheim, J. J., & Howard, O. M. Z. (2004) · PubMed · Cited by 57
Self-citationThe Severe Acute Respiratory Syndrome
Yuen, K., Wong, S. S. Y., & Peiris, M. J. S. (2006) · Springer eBooks · doi:10.1007/978-0-387-32830-0_5 · Cited by 52
Dong, L., Xia, J., Gong, Y., Chen, Z., Yang, H., Zhang, J., He, J., & Chen, X. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/637969 · Cited by 49
Self-citationFu, Y., Yan, Y., Qin, H., Wu, S., Shi, S.-S., Zheng, X., Wang, P., Chen, X., Tang, X., & Jiang, Z.-Y. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0199-4 · Cited by 48
Self-citationChinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)
Liu, X., Zhang, M., He, L., & Li, Y. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004882.pub2 · Cited by 47
Self-citationDu, C. Y. Q., Zheng, Y., Bi, C. W. C., Dong, T. T.-X., Lin, H., & Tsim, K. W. K. (2015) · Phytotherapy Research · doi:10.1002/ptr.5290 · Cited by 42
Chen, X., Mellon, R. D., Yang, L., Dong, H., Oppenheim, J. J., & Howard, O. M. Z. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00917-0 · Cited by 38
Self-citationZou, H., He, T., & Chen, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.040 · Cited by 34
Self-citationSevere Acute Respiratory Syndrome: Pertinent Clinical Characteristics and Therapy
File, T. M., & Tsang, K. W. (2005) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200504020-00003 · Cited by 17
Cited by
The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis
Galanakis, C. M. (2020) · Foods · doi:10.3390/foods9040523 · Cited by 926
Wang, J., Jiang, M., Chen, X., & Montaner, L. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3covr0520-272r · Cited by 741
Self-citationAn Update on Current Therapeutic Drugs Treating COVID-19
Wu, R., Wang, L., Kuo, H.-C. D., Shannar, A., Peter, R., Chou, P. J., Li, S., Hudlikar, R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 599
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Mani, J. S., Johnson, J. B., Steel, J. C., Broszczak, D. A., Neilsen, P. M., Walsh, K. B., & Naiker, M. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197989 · Cited by 450
Liao, H., Ye, J., Gao, L., & Liu, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110917 · Cited by 333
Metadata
- Authors
- Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2020
- Volume
- 16
- Issue
- 10
- Pages
- 1708-1717
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W3012702001
- Cited by
- 960
- References
- 81
- FWCI
- 200.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.